Inventiva IVA
NASDAQ IVA
$3.89 +0.06 (+1.43%)
As of: Nov 10, 2026 · 3:20 PM EST

Inventiva (IVA) Notes Payables (2018 - 2026)

Updated

Inventiva's Notes Payables came in at $15.5 million for Q2 2026, down 71.3% from $53.99 million a year earlier.

Analysis

Inventiva (IVA) Notes Payables (2018 - 2026) Analysis & Trends

Going back to Q4 2018, Inventiva's Notes Payables data covers 11 quarters.

  • Notes Payables carries a five-year compound annual growth rate of 276.3% (FY2020 to FY2025).
  • Going back by year, Notes Payables was $48.3 million in FY2024 (+65.0%), $29.27 million in FY2023 (-3.4%) and $30.29 million in FY2022.
  • The five-year range for quarterly Notes Payables is $15.5 million (Q4 2025) to $53.99 million (Q2 2025).
  • Year-over-year, Notes Payables increased in two of the last four quarters, with an average decline of 14.1%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Inventiva 732.26 Mn 182.20 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 60.53 Mn
Dec 31, 2025 60.19 Mn
Jun 30, 2025 55.93 Mn
Dec 31, 2024 47.03 Mn
Jun 30, 2024 -1.43 Mn
Dec 31, 2023 30.11 Mn
Jun 30, 2023 30.70 Mn
Dec 31, 2022 31.65 Mn
Dec 31, 2020 22,139.81
Dec 31, 2019 126,585.96
Dec 31, 2018 172,743.18
API Access

Inventiva Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=IVA&period=max&api_key=YOUR_API_KEY